A detailed history of Southpoint Capital Advisors LP transactions in Illumina, Inc. stock. As of the latest transaction made, Southpoint Capital Advisors LP holds 1,100,000 shares of ILMN stock, worth $108 Million. This represents 3.05% of its overall portfolio holdings.

Number of Shares
1,100,000
Previous 500,000 120.0%
Holding current value
$108 Million
Previous $39.7 Million 164.56%
% of portfolio
3.05%
Previous 1.15%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$70.3 - $95.41 $42.2 Million - $57.2 Million
600,000 Added 120.0%
1,100,000 $105 Million
Q1 2025

May 15, 2025

BUY
$79.34 - $144.22 $39.7 Million - $72.1 Million
500,000 New
500,000 $39.7 Million
Q2 2024

Aug 14, 2024

BUY
$101.05 - $133.57 $20.2 Million - $26.7 Million
200,000 New
200,000 $20.9 Million
Q2 2023

Aug 14, 2023

BUY
$183.43 - $232.67 $91.7 Million - $116 Million
500,000 New
500,000 $93.7 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $15.5B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Southpoint Capital Advisors LP Portfolio

Follow Southpoint Capital Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Southpoint Capital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Southpoint Capital Advisors LP with notifications on news.